Form 4 for OGN Organon & Co.
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-05 · accession 0001209191-23-045067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-08 | 2023-08-05 | OGN | WALSH MATTHEW M | CFO | M - OptEx | — | +22.3K | 63.4K | +54% | — |
| D | 2023-08-08 | 2023-08-05 | OGN | WALSH MATTHEW M | CFO | F - Tax | $21.53 | -11.0K | 52.4K | -17% | -$237.0K |
| D | 2023-08-08 | 2023-08-05 | OGN | WALSH MATTHEW M | CFO | M - OptEx | $0.00 | -22.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-05 | M | A | 22,347 | — | 63,417 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. |
| 2 | Common | Common Stock | 2023-08-05 | F | D | 11,006 | $21.53 | 52,411 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-08-05 | M | D | 22,347 | $0.00 | 0 | D | — · 2023-08-05 to 2023-08-05 | 22,347 Common Stock | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. (F2) On each of August 5, 2021, August 5, 2022 and August 5, 2023, one-third of the RSUs vested. |